Throsby, Mark,Geuijen, Cecilia Anna Wilhelmina,Maussang-Detaille, David Andre Baptiste,Logtenberg, Ton
申请号：
AU2018246873
公开号：
AU2018246873A1
申请日:
2018.04.03
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The invention relates to the field of antibodies. In particular it relates to the field of therapeutic (human) antibodies for the treatment of ErbB-2/ErbB-3 positive cells. More in particular it relates to treating of cells comprising an NRG1 fusion gene comprising at least a portion of the NRG1-gene fused to a sequence from a different chromosomal location.
